Electronic health record design and implementation for pharmacogenomics: a local perspective

JF Peterson, E Bowton, JR Field, M Beller… - Genetics in …, 2013 - nature.com
Purpose: The design of electronic health records to translate genomic medicine into clinical
care is crucial to successful introduction of new genomic services, yet there are few …

Evaluation of research in biomedical ontologies

R Hoehndorf, M Dumontier… - Briefings in …, 2013 - academic.oup.com
Ontologies are now pervasive in biomedicine, where they serve as a means to standardize
terminology, to enable access to domain knowledge, to verify data consistency and to …

API-centric linked data integration: The open PHACTS discovery platform case study

P Groth, A Loizou, AJG Gray, C Goble, L Harland… - Journal of web …, 2014 - Elsevier
Data integration is a key challenge faced in pharmacology where there are numerous
heterogeneous databases spanning multiple domains (eg chemistry and biology). To …

Applying linked data approaches to pharmacology: Architectural decisions and implementation

AJG Gray, P Groth, A Loizou, S Askjaer… - Semantic …, 2014 - content.iospress.com
The discovery of new medicines requires pharmacologists to interact with a number of
information sources ranging from tabular data to scientific papers, and other specialized …

[HTML][HTML] A method for structuring complex clinical knowledge and its representational formalisms to support composite knowledge interoperability in healthcare

R Lario, K Kawamoto, D Sottara, K Eilbeck… - Journal of Biomedical …, 2023 - Elsevier
Introduction The use and interoperability of clinical knowledge starts with the quality of the
formalism utilized to express medical expertise. However, a crucial challenge is that existing …

Pharmacogenomics in the pocket of every patient? A prototype based on quick response codes

M Samwald, KP Adlassnig - Journal of the American Medical …, 2013 - academic.oup.com
A sizable fraction of patients experiences adverse drug events or lack of drug efficacy. A part
of this variability in drug response can be explained by genetic differences between patients …

[HTML][HTML] Search and visualization of gene-drug-disease interactions for pharmacogenomics and precision medicine research using GeneDive

M Wong, P Previde, J Cole, B Thomas… - Journal of biomedical …, 2021 - Elsevier
Background Understanding the relationships between genes, drugs, and disease states is at
the core of pharmacogenomics. Two leading approaches for identifying these relationships …

Leveraging a pharmacogenomics knowledgebase to formulate a drug response phenotype terminology for genomic medicine

Y Zhao, M Brush, C Wang, AH Wagner, H Liu… - …, 2022 - academic.oup.com
Motivation Despite the increasing evidence of utility of genomic medicine in clinical practice,
systematically integrating genomic medicine information and knowledge into clinical …

Learning from biomedical linked data to suggest valid pharmacogenes

K Dalleau, Y Marzougui, S Da Silva, P Ringot… - Journal of biomedical …, 2017 - Springer
Background A standard task in pharmacogenomics research is identifying genes that may
be involved in drug response variability, ie, pharmacogenes. Because genomic experiments …

Making data on essential pharmacogenes available for every patient everywhere: the Medicine Safety Code initiative

M Samwald, RR Freimuth - Pharmacogenomics, 2013 - Taylor & Francis
Even though pharmacogenetics holds great potential for improving the quality of pharmaco
therapy, there are several major barriers to the integration of pharmacogenetics data into rou …